145 related articles for article (PubMed ID: 24367394)
1. Modified logistic regression models using gene coexpression and clinical features to predict prostate cancer progression.
Zhao H; Logothetis CJ; Gorlov IP; Zeng J; Dai J
Comput Math Methods Med; 2013; 2013():917502. PubMed ID: 24367394
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of the top-scoring pairs of genes for prediction of prostate cancer progression.
Zhao H; Logothetis CJ; Gorlov IP
Prostate Cancer Prostatic Dis; 2010 Sep; 13(3):252-9. PubMed ID: 20386565
[TBL] [Abstract][Full Text] [Related]
3. TSG: a new algorithm for binary and multi-class cancer classification and informative genes selection.
Wang H; Zhang H; Dai Z; Chen MS; Yuan Z
BMC Med Genomics; 2013; 6 Suppl 1(Suppl 1):S3. PubMed ID: 23445528
[TBL] [Abstract][Full Text] [Related]
4. Integration of gene expression profiling and clinical variables to predict prostate carcinoma recurrence after radical prostatectomy.
Stephenson AJ; Smith A; Kattan MW; Satagopan J; Reuter VE; Scardino PT; Gerald WL
Cancer; 2005 Jul; 104(2):290-8. PubMed ID: 15948174
[TBL] [Abstract][Full Text] [Related]
5. A stochastic model for identifying differential gene pair co-expression patterns in prostate cancer progression.
Mo WJ; Fu XP; Han XT; Yang GY; Zhang JG; Guo FH; Huang Y; Mao YM; Li Y; Xie Y
BMC Genomics; 2009 Jul; 10():340. PubMed ID: 19640296
[TBL] [Abstract][Full Text] [Related]
6. Random forest-based modelling to detect biomarkers for prostate cancer progression.
Toth R; Schiffmann H; Hube-Magg C; Büscheck F; Höflmayer D; Weidemann S; Lebok P; Fraune C; Minner S; Schlomm T; Sauter G; Plass C; Assenov Y; Simon R; Meiners J; Gerhäuser C
Clin Epigenetics; 2019 Oct; 11(1):148. PubMed ID: 31640781
[TBL] [Abstract][Full Text] [Related]
7. Optimizing molecular signatures for predicting prostate cancer recurrence.
Sun Y; Goodison S
Prostate; 2009 Jul; 69(10):1119-27. PubMed ID: 19343730
[TBL] [Abstract][Full Text] [Related]
8. Gene expression profiles in prostate cancer: association with patient subgroups and tumour differentiation.
Halvorsen OJ; Oyan AM; Bø TH; Olsen S; Rostad K; Haukaas SA; Bakke AM; Marzolf B; Dimitrov K; Stordrange L; Lin B; Jonassen I; Hood L; Akslen LA; Kalland KH
Int J Oncol; 2005 Feb; 26(2):329-36. PubMed ID: 15645116
[TBL] [Abstract][Full Text] [Related]
9. A generalized covariate-adjusted top-scoring pair algorithm with applications to diabetic kidney disease stage classification in the Chronic Renal Insufficiency Cohort (CRIC) Study.
Kwan B; Fuhrer T; Montemayor D; Fink JC; He J; Hsu CY; Messer K; Nelson RG; Pu M; Ricardo AC; Rincon-Choles H; Shah VO; Ye H; Zhang J; Sharma K; Natarajan L
BMC Bioinformatics; 2023 Feb; 24(1):57. PubMed ID: 36803209
[TBL] [Abstract][Full Text] [Related]
10. AUCTSP: an improved biomarker gene pair class predictor.
Kagaris D; Khamesipour A; Yiannoutsos CT
BMC Bioinformatics; 2018 Jun; 19(1):244. PubMed ID: 29940833
[TBL] [Abstract][Full Text] [Related]
11. Using logistic regression to improve the prognostic value of microarray gene expression data sets: application to early-stage squamous cell carcinoma of the lung and triple negative breast carcinoma.
Mount DW; Putnam CW; Centouri SM; Manziello AM; Pandey R; Garland LL; Martinez JD
BMC Med Genomics; 2014 Jun; 7():33. PubMed ID: 24916928
[TBL] [Abstract][Full Text] [Related]
12. Development and Validation of an Individualized Immune Prognostic Signature for Recurrent Prostate Cancer.
Jin Y; Wang L; Lou H; Song C; He X; Ding M
Comb Chem High Throughput Screen; 2021; 24(1):98-108. PubMed ID: 32593277
[TBL] [Abstract][Full Text] [Related]
13. Application of Affymetrix array and Massively Parallel Signature Sequencing for identification of genes involved in prostate cancer progression.
Oudes AJ; Roach JC; Walashek LS; Eichner LJ; True LD; Vessella RL; Liu AY
BMC Cancer; 2005 Jul; 5():86. PubMed ID: 16042785
[TBL] [Abstract][Full Text] [Related]
14. MetaKTSP: a meta-analytic top scoring pair method for robust cross-study validation of omics prediction analysis.
Kim S; Lin CW; Tseng GC
Bioinformatics; 2016 Jul; 32(13):1966-73. PubMed ID: 27153719
[TBL] [Abstract][Full Text] [Related]
15. Robust gene network analysis reveals alteration of the STAT5a network as a hallmark of prostate cancer.
Reddy A; Huang CC; Liu H; Delisi C; Nevalainen MT; Szalma S; Bhanot G
Genome Inform; 2010; 24():139-53. PubMed ID: 22081596
[TBL] [Abstract][Full Text] [Related]
16. Prioritizing candidate disease miRNAs by topological features in the miRNA target-dysregulated network: case study of prostate cancer.
Xu J; Li CX; Lv JY; Li YS; Xiao Y; Shao TT; Huo X; Li X; Zou Y; Han QL; Li X; Wang LH; Ren H
Mol Cancer Ther; 2011 Oct; 10(10):1857-66. PubMed ID: 21768329
[TBL] [Abstract][Full Text] [Related]
17. ICP: A novel approach to predict prognosis of prostate cancer with inner-class clustering of gene expression data.
Kim H; Ahn J; Park C; Yoon Y; Park S
Comput Biol Med; 2013 Oct; 43(10):1363-73. PubMed ID: 24034727
[TBL] [Abstract][Full Text] [Related]
18. Molecular sampling of prostate cancer: a dilemma for predicting disease progression.
Sboner A; Demichelis F; Calza S; Pawitan Y; Setlur SR; Hoshida Y; Perner S; Adami HO; Fall K; Mucci LA; Kantoff PW; Stampfer M; Andersson SO; Varenhorst E; Johansson JE; Gerstein MB; Golub TR; Rubin MA; Andrén O
BMC Med Genomics; 2010 Mar; 3():8. PubMed ID: 20233430
[TBL] [Abstract][Full Text] [Related]
19. Integrating biomedical knowledge to model pathways of prostate cancer progression.
Morris DS; Tomlins SA; Rhodes DR; Mehra R; Shah RB; Chinnaiyan AM
Cell Cycle; 2007 May; 6(10):1177-87. PubMed ID: 17495538
[TBL] [Abstract][Full Text] [Related]
20. Feature selection and nearest centroid classification for protein mass spectrometry.
Levner I
BMC Bioinformatics; 2005 Mar; 6():68. PubMed ID: 15788095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
